# EDGAR Filing Document

**Accession Number:** 0001819704
**File Stem:** 0001104659-23-039646
**Filing Date:** 2023-3
**Character Count:** 6095
**Document Hash:** 53848e35176df9450af1dac8422fcb67
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-039646.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001104659-23-039646

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230331

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medirom Healthcare Technologies Inc.
- **CENTRAL INDEX KEY:** 0001819704
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PERSONAL SERVICES [7200]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** M0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39809
- **FILM NUMBER:** 23783362

**BUSINESS ADDRESS:**
- **STREET 1:** 2-3-1 DAIBA, MINATO-KU
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 135-0091
- **BUSINESS PHONE:** 81-3-6721-7364

**MAIL ADDRESS:**
- **STREET 1:** 2-3-1 DAIBA, MINATO-KU
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 135-0091

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of March, 2023**

**Commission File Number 001-39809**

**MEDIROM HEALTHCARE TECHNOLOGIES INC.**

(Translation of registrant's name into English)

**2-3-1 Daiba, Minato-ku<br> Tokyo 135-0091, Japan**

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

⌧ Form 20-F ◻ Form 40-F

**INFORMATION CONTAINED IN THIS FORM 6-K REPORT**

<u>Results of Ordinary General Meeting of Shareholders</u>

The 23rd Ordinary General Meeting (the "Annual Meeting") of shareholders of MEDIROM Healthcare Technologies Inc. (the "Company") was held on March 31, 2023 at 9:00 a.m., Japan Standard Time (March 30, 2023 at 8:00 p.m., U.S. Eastern Time) in Tokyo, Japan. At the Annual Meeting, the shareholders of the Company approved and adopted all of the four resolutions as originally proposed as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;**No.** | &nbsp;&nbsp;**Proposal** |
| &nbsp;&nbsp;1. | &nbsp;&nbsp;Approval of the amendment of the Articles of Incorporation of the Company; |
| &nbsp;&nbsp;2. | &nbsp;&nbsp;Approval of the reduction in the registered paid-in capital and additional reserved capital by re-classifying as other capital surplus in Company's book and the disposition of such re-classified other capital surplus, offset against accumulated deficit; |
| &nbsp;&nbsp;3. | &nbsp;&nbsp;Re-election of four (4) Directors to serve for the ensuing year as members of the Board of Directors; and |
| &nbsp;&nbsp;4. | &nbsp;&nbsp;Ratification of the appointment of Crea Audit Corporation as the Accounting Auditor (which is responsible for the audit in Japan under the local laws) for the Company. |

---

<u>Other Events</u>

On March 31, 2023, the Company issued a notice announcing the results of the Annual Meeting.

The notice furnished in this report as Exhibit 99.1 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

**EXHIBIT INDEX**

<u>Exhibit No.</u> <u>Description</u> <br> [99.1](tm2310986d1_ex99-1.htm) [Notice of Resolution of the 23rd Ordinary General Meeting of Shareholders held on March 31, 2023 \[English translation\]](tm2310986d1_ex99-1.htm)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | MEDIROM HEALTHCARE TECHNOLOGIES INC. | MEDIROM HEALTHCARE TECHNOLOGIES INC. |
| Date: March 31, 2023 |  |  |
|  | By: | */s/ Fumitoshi Fujiwara* |
|  |  | Name: Fumitoshi Fujiwara |
|  |  | Title: Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| 【**Note**】 | **This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for direct, indirect or any other forms of damages arising from the translation.** |

---

Ticker: MRM

March 31, 2023

---

| |
|:---|
| Kouji Eguchi |
| CEO and Representative Director |
| **MEDIROM Healthcare Technologies Inc.** |
| 2-3-1 Daiba, Minato-ku, |
| Tokyo, Japan, 135-0091 |

---

Dear Shareholders:

**Notice of Resolution of the 23rd Ordinary General Meeting of Shareholders**

**held on March 31, 2023**

The 23rd Ordinary General Meeting (the "Annual Meeting") of shareholders of MEDIROM Healthcare Technologies Inc. (the "Company") was held on March 31, 2023 at 9:00 a.m., Japan Standard Time (March 30, 2023 at 8:00 p.m., U.S. Eastern Time) in Tokyo, Japan. At the Annual Meeting, the shareholders of the Company approved and adopted all of the four resolutions as originally proposed as follows:

---

| | |
|:---|:---|
| &nbsp;&nbsp;**No.** | &nbsp;&nbsp;**Proposal** |
| &nbsp;&nbsp;1. | &nbsp;&nbsp;Approval of the amendment of the Articles of Incorporation of the Company; |
| &nbsp;&nbsp;2. | &nbsp;&nbsp;Approval of the reduction in the registered paid-in capital and additional reserved capital by re-classifying as other capital surplus in Company's book and the disposition of such re-classified other capital surplus, offset against accumulated deficit; |
| &nbsp;&nbsp;3. | &nbsp;&nbsp;Re-election of four (4) Directors to serve for the ensuing year as members of the Board of Directors; and |
| &nbsp;&nbsp;4. | &nbsp;&nbsp;Ratification of the appointment of Crea Audit Corporation as the Accounting Auditor (which is responsible for the audit in Japan under the local laws) for the Company. |

---

For further information, please contact our Investor Relations.

■Contacts<br> Investor Relations Team: ir@medirom.co.jp